Large-scale testing (Phase 3)Study completedNCT04464707
What this trial is testing
Test if Fremanezumab is Effective in Preventing Chronic Migraine in Participants 6 to 17 Years of Age
Who this might be right for
Migraine
Teva Branded Pharmaceutical Products R&D, Inc. 292